NDC codes

FDA NDC Directory
Product NDC (as listed)44523-182Labeler and product segments. Claims need a package NDC.
Product NDC at billing width44523-0182Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
44523-182-084452301820844523018208237 mL in 1 BOTTLE (44523-182-08)Marketed from Oct 28, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Generic name (nonproprietary)
prednisolone sodium phosphate
Active ingredients
Prednisolone sodium phosphate — 25 mg/5mL
Dosage form
Solution
Route
Oral
Labeler
BioComp Pharma, Inc.NDC labeler code 44523
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 091396
Marketing start
Listing expires
Other FDA classes
Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers
Product ID 44523-182_450e8d3f-b6f6-5251-e063-6394a90aa439SPL ID 450e8d3f-b6f6-5251-e063-6394a90aa439SPL set ID 95208441-1700-5d3f-e053-2a95a90a7da2RxCUI 249066UNII IV021NXA9JUPC 0344523182080
Pharmacologic class
Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444523018208 followed by a unit qualifier and the quantity

Package 44523-0182-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Prednisolone sodium phosphate oral solution (25 mg prednisolone per 5 mL) is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. Dermatologic Diseases Pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative erythroderma; mycosis fungoides. 3. Edematous States To induce diuresis or remission of proteinuria in nephrotic sy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 44523-182

What is NDC 44523-182?
44523-182 is the product NDC for Prednisolone Sodium Phosphate Oral Solution, Prednisolone sodium phosphate 25 mg/5mL solution, listed with the FDA by BioComp Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Prednisolone Sodium Phosphate Oral Solution (Prednisolone Sodium Phosphate).
What is the active ingredient?
Prednisolone sodium phosphate.
Who is the labeler?
BioComp Pharma, Inc., NDC labeler code 44523. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Prednisolone Sodium Phosphate Oral Solution?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in